Ovariectomy Reinstates the Infarct Size-Limiting Effect of Postconditioning in Female Rabbits

Cell Biochemistry and Biophysics

Volumn 65, Issue 3, 2013, Pages 373-380

  Demerouti, Eftychia ^a   Andreadou, Ioanna ^b   Aggeli, Ioanna Katerina ^b   Farmakis, Dimitrios ^a   Zoga, Anastasia ^a   Gaitanaki, Catherine ^b   Beis, Isidoros ^b   Anastasiou Nana, Maria ^a   Kremastinos, Dimitrios Th ^a   Iliodromitis, Efstathios K ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

Author keywords

Intracellular signaling; Myocardial infarction; Ovariectomy; Postconditioning

Indexed keywords

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 84875222477     PISSN: 10859195     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12013-012-9441-3     Document Type: Article

References (52)

1. Zhao, Z. Q., Corvera, J. S., Halkos, M. E., Kerendi, F., Wang, N. P., Guyton, R. A., et al. (2003). Inhibition of myocardial injury by ischemic postconditioning during reperfusion: Comparison with ischemic preconditioning (PreC). American Journal of Physiology-Heart and Circulatory Physiology, 285, H579-H588.
2. Hausenloy, D. J., & Yellon, D. M. (2004). New directions for protecting the heart against ischaemia-reperfusion injury: Targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway. Cardiovascular Research, 61, 448-460.
3. Hausenloy, D. J., & Yellon, D. M. (2003). The mitochondrial permeability transition pore: Its fundamental role in mediating cell death during ischaemia and reperfusion. Journal of Molecular and Cellular Cardiology, 35, 339-341.
4. Staat, P., Rioufol, G., Piot, C., Cottin, Y., Cung, T. T., L'Huillier, I., et al. (2005). Postconditioning the human heart. Circulation, 112, 2143-2148.
5. Thibault, H., Piot, C., Staat, P., Bontemps, L., Sportouch, C., Rioufol, G., et al. (2008). Long-term benefit of postconditioning. Circulation, 117, 1037-1044.
6. Hansen, R. R., Thibault, H., & Abdulla, J. (2010). Postconditioning during primary percutaneous coronary intervention: A review and meta-analysis. International Journal of Cardiology, 144, 22-25.
7. Iliodromitis, E. K., Zoga, A., Vrettou, A., Andreadou, I., Paraskevaidis, I. A., Kaklamanis, L., et al. (2006). The effectiveness of postconditioning and preconditioning on infarct size in hypercholesterolemic and normal anesthetized rabbits. Atherosclerosis, 188, 356-362.
8. Bouhidel, O., Pons, S., Souktani, R., Zini, R., Berdeaux, A., & Ghaleh, B. (2008). Myocardial ischemic postconditioning against ischemia-reperfusion in impaired in ob/ob mice. American Journal of Physiology-Heart and Circulatory Physiology, 295, H1580-H1586.
9. Boengler, K., Schulz, R., & Heusch, G. (2009). Loss of cardioprotection with ageing. Cardiovascular Research, 83, 247-261.
10. Barret-Connor, E. (1997). Sex differences in coronary heart disease. Why are women so superior? The 1995 Ancel Keys Lecture. Circulation, 95, 252-264.
11. Culic, V., Miric, D., & Jukic, I. (2003). Acute myocardial infarction: Differing preinfarction and clinical features according to infarct size and gender. International Journal of Cardiology, 90, 189-196.
12. Antonicelli, R., Olivieri, F., Morichi, V., Urbani, E., & Mais, V. (2008). Prevention of cardiovascular events in early menopause: A possible role for hormone replacement therapy. International Journal of Cardiology, 130, 140-146.
13. Shinmura, K., Nagai, M., Tamaki, K., & Bolli, R. (2008). Loss of ischemic preconditioning in ovariectomized rat hearts: Possible involvement of impaired protein kinase C ε phosphorylation. Cardiovascular Research, 79, 387-394.
14. Sbarouni, E., Iliodromitis, E., Zoga, A., Vlachou, G., Andreadou, I., & Kremastinos, D. T. (2006). The effect of the phytoestrogen genistein on myocardial protection, preconditioning and oxidative stress. Cardiovascular Drugs and Therapy, 20, 253-258.
15. Penna, C., Tullio, F., Merlino, A., Moro, F., Raimondo, S., Rastaldo, R., et al. (2009). Postconditioning cardioprotection against infarct size and post-ischemic systolic dysfunction is influenced by gender. Basic Research in Cardiology, 104, 390-402.
16. Crisostomo, P., Wang, M., Wairiuko, G. M., Terrell, A. M., & Meldrum, D. R. (2006). Postconditioning in females depends on injury severity. Journal of Surgical Research, 134, 342-347.
17. Dow, J., & Kloner, R. A. (2007). Postconditioning does not reduce myocardial infarct size in an in vivo regional ischemia rodent model. The Journal of Cardiovascular Pharmacology and Therapeutics, 12, 153-163.
18. Lee, D. S., Steinbaugh, G. E., Quarrie, R., Yang, F., Talukder, M. A., Zweier, J. L., et al. (2010). Ischemic postconditioning does not provide cardioprotection from long-term ischemic injury in isolated male or female rat hearts. Journal of Surgical Research, 164, 178-181.
19. Zheng, Z., Yang, M., Zhang, F., Yu, J., Wang, J., Ma, L., et al. (2011). Gender-related difference of sevoflurane postconditioning in isolated rat hearts: Focus on phosphatidylinositol-3-kinase/Akt signaling. Journal of Surgical Research, 170, e3-e9.
20. Iliodromitis, E. K., Andreadou, I., Prokovas, E., Zoga, A., Farmakis, D., Fotopoulou, T., et al. (2010). Simvastatin in contrast to postconditioning reduces infarct size in hyperlipidemic rabbits: Possible role of oxidative/nitrosative stress. Basic Research in Cardiology, 105, 193-203.
21. Aggeli, I. K., Gaitanaki, C., & Beis, I. (2006). Involvement of JNKs and p38-MAPK/MSK1 pathways in H2O2-induced upregulation of heme oxygenase-1 mRNA in H9c2 cells. Cellular Signalling, 18, 1801-1812.
22. Bogoyevitch, M. A. (2000). Signalling via stress-activated mitogen-activated protein kinases in the cardiovascular system. Cardiovascular Research, 45, 826-842.
23. Argaud, L., Gateau- Roesch, O., Raisky, O., Loufouat, J., Robert, D., & Ovize, M. (2005). Postconditioning inhibits mitochondrial permeability transition. Circulation, 111, 194-197.
24. Tsang, A., Hausenloy, D. J., Mocanu, M. M., & Yellon, D. M. (2004). Postconditioning: A form of "modified reperfusion" protects the myocardium by activating the phosphatidylinositol 3-kinase-Akt pathway. Circulation Research, 95, 230-232.
25. Yang, X. M., Proctor, J. B., Cui, L., Krieg, T., Downey, J. M., & Cohen, M. V. (2004). Multiple, brief coronary occlusions during early reperfusion protect rabbit hearts by targeting cell signalling pathways. Journal of the American College of Cardiology, 44, 1103-1110.
26. Roubille, F., Franck-Miclo, A., Covinches, A., Lafont, C., Cransac, F., Combes, S., et al. (2011). Delayed postconditioning in the mouse heart in vivo. Circulation, 124, 1330-1336.
27. Iliodromitis, E., & Kremastinos, D. (2006). From preconditioning to postconditioning: Novel interventions in the armory of salvage of the ischemic heart. Hellenic Journal of Cardiology, 47, 321-323.
28. Kim, J. K., & Levin, E. R. (2006). Estrogen signaling in the cardiovascular system. Nuclear Receptor Signaling, 4, e013.
29. Hayashi, T., Fukuto, J. M., Ignarro, L. J., & Chaudhuri, G. (1992). Basal release of nitric oxide from aortic rings is greater in female rabbits than in male rabbits: Implications for atherosclerosis. Proceeding of National Academy of Science USA, 89, 11259-11263.
30. Hayashi, T., Fukuto, J. M., Ignarro, L. J., & Chaudhuri, G. (1995). Gender difference in atherosclerosis: Possible role of nitric oxide. Journal of Cardiovascular Pharmacology, 26, 792-802.
31. 3 in plasma after experimental myocardial infarction. Journal of Molecular and Cellular Cardiology, 29, 1-7.
32. Andreadou, I., Iliodromitis, E. K., Mikros, E., Constantinou, M., Agalias, A., Magiatis, P., et al. (2006). The olive constituent oleuropein exhibits anti-ischemic, antioxidative and hypolipidemic effects in anesthetized rabbits. Journal of Nutrition, 136, 2213-2219.
33. Shuto, H., Tominaga, K., Yamanuchi, A., Ikeda, M., Kusaba, K., Mitsunaga, D., et al. (2011). The statins fluvastatin and pravastatin exert anti-flushing effects by improving vasomotor dysfunction through nitric oxide-mediated mechanism in ovariectomized animals. European Journal of Pharmacology, 651, 234-239.
34. Akiyama, K., Kimura, A., Suzuki, H., Takeyama, Y., Gluckman, T. L., Tarhakopian, A., et al. (1998). Production of oxidative products of nitric oxide in infracted human heart. Journal of the American College of Cardiology, 32, 373-379.
35. Andreadou, I., Farmakis, D., Prokovas, E., Sigala, F., Zoga, A., Spyridaki, K., et al. (2012). Short-term statin administration in hypercholesterolemic rabbits resistant to postconditioning: Effects on infarct size, endothelial nitric oxide synthase and nitro-oxidative stress. Cardiovascular Research, 94, 501-509.
36. Salloum, F. N., Takenoshita, Y., Ockaili, R. A., Daoud, V. P., Chou, E., Yoshida, K., et al. (2007). Sildenafil and vardenafil but not nitroglycerin limit myocardial infarction through opening of mitochondrial KATP channels when administered at reperfusion following ischemia in rabbits. Journal of Molecular and Cellular Cardiology, 42, 453-458.
37. Takeuchi, K., McGowan, F. X., Danh, H. C., Glynn, P., Simplaceanu, E., & delNido, P. J. (1995). Direct detrimental effects of l-arginine upon ischemia reperfusion injury to myocardium. Journal of Molecular and Cellular Cardiology, 27, 1405-1414.
38. Wang, M., Baker, L., Tsai, B. M., Meldrum, K. K., & Meldrum, D. R. (2005). Sex differences in the myocardial inflammatory response to ischemia reperfusion injury. The American Journal of Physiology-Endocrinology and Metabolism, 288, E321-E326.
39. van Eickels, M., Groh′e, C., Cleutjens, J. P., Janssen, B. J., Wellens, H. J., & Doevendans, P. A. (2001). 17β-Estradiol attenuates the development of pressure-overload hypertrophy. Circulation, 104, 1419-1423.
40. Wang, M., Crisostomo, P., Wairiuko, G. M., & Meldrum, D. R. (2006). Estrogen receptor-α mediates acute myocardial protection in females. American Journal of Physiology-Heart and Circulatory Physiology, 290, H2204-H2209.
41. Beer, S., Reincke, M., Kral, M., Callies, F., Strömer, H., Dienesch, C., et al. (2007). High-dose 17β-estradiol treatment prevents development of heart failure post-myocardial infarction in the rat. Basic Research in Cardiology, 102, 9-18.
42. Hugel, S., Reincke, M., Stromer, H., Winning, J., Horn, M., Dienesch, C., et al. (1999). Evidence against a role of physiological concentrations of estrogen in post-myocardial infarction remodeling. Journal of the American College of Cardiology, 34, 1427-1434.
43. van Eickels, M., Patten, R. D., Aronovitz, M. J., Alsheikh-Ali, A., Gostyla, K., Celestin, F., et al. (2003). 17-β-Estradiol increases cardiac remodeling and mortality in mice with myocardial infarction. Journal of the American College of Cardiology, 41, 2084-2092.
44. Song, X., Li, G., Vaage, J., & Valen, G. (2003). Effects of sex, gonadectomy, and oestrogen substitution on ischaemic preconditioning and ischemia-reperfusion injury in mice. Acta Physiologica Scandinavica, 177, 459-466.
45. Peng, W. J., Yu, J., Deng, S., Jiang, J. L., Deng, H. W., & Li, Y. J. (2004). Effect of estrogen replacement treatment on ischemic preconditioning in isolated rat hearts. Canadian Journal of Physiology and Pharmacology, 82, 339-344.
46. Stampfer, M. J., Colditz, G. A., Willett, W. C., Manson, J. E., Rosner, B., Speizer, F. E., et al. (1991). Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses health study. New England Journal of Medicine, 325, 756-762.
47. Wenger, N. K., Speroff, L., & Packard, B. (1993). Cardiovascular health and disease in women. New England Journal of Medicine, 329, 247-256.
48. Alexandersen, P., Tank′o, L. B., Bagger, Y. Z., Qin, G., & Christiansen, C. (2006). The long-term impact of 2-3 years of hormone replacement therapy on cardiovascular mortality and atherosclerosis in healthy women. Climacteric, 9, 108-118.
49. Hulley, S., Grady, D., Bush, T., Furberg, C., Herrington, D., Riggs, B., et al. (1998). Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS). JAMA, 280, 605-613.
50. Grady, D., Herrington, D., Bittner, V., Blumenthal, R., Davidson, M., Hlatky, M., et al. (2002). Cardiovascular disease outcomes during 6. 8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). JAMA, 288, 49-57.
51. Rossouw, J. E., Andersen, G. L., Prentice, R. L., LaCroix, A. Z., Kooperberg, C., Stefanick, M. L., et al. (2002). Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial. JAMA, 288, 321-333.
52. Hendrix, S. L., Wassertheil-Smoller, S., Johnson, K. C., Howard, B. V., Kooperberg, C., Rossouw, J. E., et al. (2006). Effects of conjugated equine estrogen on stroke in the Women's Health Initiative. Circulation, 113, 2425-2434.